Topics
January/February 2016 | Special Focus: Inside The Treatment Pipeline
Reversing Retinal Ischemia
Using encapsulated cell technology, a novel device may some day be used to treat inadequate oxygenation associated with common diseases.
Logan Christensen, MD, and Jeffrey L. Olson, MD
October 30, 2026
Octant Receives FDA Orphan Drug Designation for OCT-980 for the Treatment of Retinitis Pigmentosa
VisioSurgical Solutions Begins Development of Compact Surgical Robot for Retinal Surgery
October 29, 2026
Oculis to Present Privosegtor Data at Upcoming Ophthalmology and Neurology Conferences
Kiora Plans Multinational Phase 3 CRAO and Phase 2b NAION Trials of KIO-401
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
